NCT04407169

Prevalence of Critical Forms of CoVid-19 in Patients With Chronic Respiratory Disease

Evaluation of the Prevalence of Critical Forms of CoVid-19 in Patients With Chronic Respiratory Disease Hospitalized for Severe Forms

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 617 (actual)
• Sponsor: Central Hospital, Nancy, France · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

A new Coronavirus (SARS-CoV-2) emerged in Wuhan Province, China in December 2019 and rapidly spread around the world. To date, the data in the literature regarding the clinical and epidemiological characteristics of severe forms of CoVid-19 in patients with chronic respiratory disease are not well known. The hypothesis is that patients with chronic respiratory disease (COPD, asthma, bronchial dilatations, pulmonary hypertension, cystic fibrosis, obesity-hypoventilation syndrome, obstructive sleep apnea syndrome) infected with SARS-Cov-2 will have increased dyspnea and hypoxemia leading to hospitalization for severe forms more frequently than the general population. However, they do not appear to be more at risk of developing a critical form. This study is carried out in order to propose to estimate the prevalence of critical forms of CoVid19 among patients with chronic respiratory diseases hospitalized for severe forms.

Conditions

• COVID

Interventions

Type	Name	Description
OTHER	no intervention	There will be no intervention. It is only an observationnal study

Timeline

• Start date: 2020-06-01
• Primary completion: 2020-11-17
• Completion: 2020-11-17
• First posted: 2020-05-29
• Last updated: 2020-11-20

Locations

1 site across 1 country: France